Stocks
Intercept Pharmaceuticals (ICPT) EBITDA margin US GAAP (year values) |
|||||||||
| FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -155.0% | -116.9% | -67.9% | -9.59% | -21.6% | -11.0% | ||
| Changes by years, y/y, % | +98pp | +38pp | +49pp | +58pp | -12pp | -38.9% | |||
Intercept Pharmaceuticals. EBITDA margin, %
Intercept Pharmaceuticals. EBITDA margin, changes, pp
Intercept Pharmaceuticals (ICPT) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2022Q3 | FY2022Q4 | FY2023Q1 | FY2023Q2 | FY2023Q3 | LTM ? | |||
| EBITDA margin, % | ? | -9.86% | -19.1% | -39.0% | 1.30% | 5.80% | -11.0% | |
| Changes by years, y/y, % | -21pp | +4pp | -27pp | +21pp | +16pp | |||
| Changes by quarters, q/q, % | +10pp | -9pp | -20pp | +40pp | +4pp | |||
